3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Mp: new trials by email Literature Review of Mp trials Research Report on Mp
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia vincristine sulfate, prednisone, doxorubicin hydrochloride - B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia | Phase 3 | Completed | Children's Oncology Group | 275 | 2007-03-01 | 2024-03-26 |
| Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia filgrastim, asparaginase, cyclophosphamide - Childhood Acute Lymphoblastic Leukemia in Remission, Recurrent Childhood Acute Lymphoblastic Leukemia | Phase 3 | Completed | National Cancer Institute (NCI) | 220 | 2002-10-01 | 2014-02-27 |
| Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia tretinoin, daunorubicin hydrochloride, cytarabine - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Promyelocytic Leukemia (M3) | Phase 3 | Completed | National Cancer Institute (NCI) | 420 | 1999-06-01 | 2013-06-05 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Leukemia, Promyelocytic, Acute (1)
National Cancer Institute (NCI) (2) · Children's Oncology Group (1)
United States (3) · Australia (1) · Canada (1) · Switzerland (1)
Bayard Powell (1) · Glen Lew, MD (1) · Kirk Schultz (1)
PMID 20705755, PMID 32001530, PMID 33242441
U10CA098543 (2), U10CA031946 (1)